4 recruiting, 4 unknown, 1 completed, 1 terminated. 10 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 10 | Recruiting 4, Unknown 4, Completed 1, Terminated 1 |
Follow Osteosarcoma: new trials by email Literature Review of Osteosarcoma trials Research Report on Osteosarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors Methionine-Reduced Diet - Adenocarcinoma, Basal Cell Carcinoma | Early Phase 1 | Recruiting | University of California, Irvine | 25 | 2026-05-01 | 2026-07-31 |
| 68Ga-B7-H3 Nanobody ImmunoPET in Osteosarcoma 68Ga-B7-H3 Nanobody PET/CT - Osteosarcoma, Osteosarcoma, Recurrent, Refractory | Early Phase 1 | Recruiting | Peking University First Hospital | 16 | 2026-04-01 | 2026-08-19 |
| PET-imaging of Two Vartumabs in Patients With Solid Tumors 89Zr-DFO-N-Suc-F8scFv, 89Zr-DFO-N-Suc-C9scFv, PET/CT scan - Solid Tumor, Colon Carcinoma | Early Phase 1 | Recruiting | Var2 Pharmaceuticals | 32 | 2024-12-10 | 2025-12-29 |
| Single Arm Romiplostim to Prevent CIT Romiplostim (AMG-531) - Ewings Sarcoma, Chemotherapy Induced Thrombocytopenia | Early Phase 1 | Recruiting | Children's Hospital Medical Center, Cincinnati | 26 | 2024-01-26 | 2026-03-18 |
| A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors Recombinant oncolytic herpes simplex virus type Ⅰ (R130) - Osteosarcoma, Sarcoma | Early Phase 1 | Unknown | Shanghai Yunying Medical Technology | 9 | 2023-07-12 | 2023-12-14 |
| A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Bone and Soft Tissue Tumors Recombinant oncolytic herpes simplex virus type Ⅰ (R130) - Osteosarcoma, Sarcoma | Early Phase 1 | Unknown | Shanghai Yunying Medical Technology | 20 | 2023-04-10 | 2023-05-09 |
| Safety and Efficacy of NK510 to Treat Osteosarcoma and Soft Tissue Sarcoma NK510 - Osteosarcoma, Soft Tissue Sarcoma | Early Phase 1 | Unknown | Base Therapeutics (Shanghai) Co., Ltd. | 12 | 2022-09-01 | 2023-11-07 |
| Clinical Study of CD276 Targeted Autologous Chimeric Antigen Receptor T Cell Infusion in Patients With CD276 Positive Advanced Solid Tumor Targeting CD276 CAR T cells - Osteosarcoma, Neuroblastoma | Early Phase 1 | Unknown | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 24 | 2021-05-14 | 2021-05-06 |
| Glucarpidase After High-Dose Methotrexate in Patients With Osteosarcoma Glucarpidase, Quality-of-Life Assessment - Osteosarcoma | Early Phase 1 | Completed | OHSU Knight Cancer Institute | 11 | 2019-03-27 | 2026-07-07 |
| Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer cyclophosphamide, Cryoablation - Cancer | Early Phase 1 | Terminated | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 19 | 2007-06-01 | 2019-01-18 |
Sarcoma (6) · Bone Neoplasms (2) · Breast Neoplasms (2) · Chondrosarcoma (2) · Colonic Neoplasms (2) · Lung Neoplasms (2) · Melanoma (2) · Neoplasms (2) · Pancreatic Neoplasms (2) · Sarcoma, Ewing (2) · Squamous Cell Carcinoma of Head and Neck (2) · Stomach Neoplasms (2) · Adenocarcinoma (1) · Breast Neoplasms, Male (1)
Neoplasms by Histologic Type (10) · Neoplasms, Bone Tissue (10) · Neoplasms, Connective Tissue (10) · Neoplasms, Connective and Soft Tissue (10) · Neoplasms (8) · Neoplasms by Site (6) · Neoplasms, Glandular and Epithelial (4) · Neoplasms, Nerve Tissue (4) · Neoplasms, Neuroepithelial (4) · Neuroectodermal Tumors (4) · Sarcoma (4) · Carcinoma (3) · Digestive System Diseases (3) · Digestive System Neoplasms (3) · Endocrine System Diseases (3)
Cryosurgery (1) · Cyclophosphamide (1) · gamma-Glutamyl Hydrolase (1) · glucarpidase (1) · romiplostim (1)
Shanghai Yunying Medical Technology (2) · Base Therapeutics (Shanghai) Co., Ltd. (1) · Children's Hospital Medical Center, Cincinnati (1) · OHSU Knight Cancer Institute (1) · Peking University First Hospital (1) · PersonGen BioTherapeutics (Suzhou) Co., Ltd. (1) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1) · University of California, Irvine (1) · Var2 Pharmaceuticals (1)
China (4) · United States (4) · Netherlands (1)
Brian Turpin, DO (1) · Christopher Ryan (1) · Gooitzen van Dam, MD, PhD (1) · Ronald Rodriguez, MD, PhD (1) · Yingqi Hua, phD (1) · Zhaohui A Arter, MD (1)
P30CA006973 (1)